Vantage logo

Fibrocell gets a reality check

Promising data with Fibrocell’s epidermolysis bullosa gene therapy send the company down as funding worries kick in.

Vantage logo

Proqr hits the gas on blindness project

Encouraging early data have persuaded the Dutch RNA researcher to push straight into a pivotal trial of its Leber’s congenital amaurosis project, raising hopes for an…